Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-03

Clinical Trial Update: PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine [Phase 1]

View source ↗

Summary

A Phase 1 study of PF-00477736 in combination with gemcitabine in advanced solid tumors was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemcitabine)
  • PF-00477736

Snippet

Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2012-04-03